XVIVO Perfusion AB (3XV)
Market Open
15 Jun, 06:07
€
25. 66
+1.52
+6.2966%
€
- Market Cap
384.18 P/E Ratio
- Div Yield
47 Volume
1.4 Eps
€ 24.14
Previous Close Want to track 3XV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 1.17 | - |
| | | - | - |
| | | 2.06 | - |
| | | 0.63 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
3XV Earnings Reports FAQ
What is the earnings per share (EPS) for 3XV?
The current EPS is 1.4.
What is the company's earnings growth rate?
XVIVO Perfusion AB has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
XVIVO Perfusion AB has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for XVIVO Perfusion AB are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 3XV at this time, as XVIVO Perfusion AB has no recent EPS data to calculate it.
